Roquefort Therapeutics PLC at OTC Markets Life Science Investor Forum (Virtual) Transcript
Hello, and welcome to Virtual Investor Conferences. My name's Bob power. And on behalf of OTC Markets, we're very pleased you've joined us for our next live presentation from Roquefort Therapeutics plc.
Before I introduce our speaker, a few points to note. (Conference Instructions)
On a final note, all of today's presentations will be recorded and available for 24/7 replay.
At this point, I'm very pleased to welcome Ajan Reginald, Chief Executive Officer of Roquefort Therapeutics plc, which trades on the OTCQB Venture Market under the symbol ROQAF and on the LSE under the symbol ROQ. Welcome, Arjan.
Thank you very much. Great to be here. So without further ado, I'm going to take us through the slides. And just to repeat, the company is Roquefort Therapeutics, and I'm the CEO, Ajan Reginald.
So a quick company history. Roquefort Therapeutics was founded in 2020 and listed on the London Stock Exchange in 2021. In December '21, Roquefort
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |